Evidence map›Paper›PMID 21295589›Full record

ArticleJournal of theoretical biology2011

Modeling the host response to inhalation anthrax.

Judy Day, Avner Friedman, Larry S Schlesinger

Abstract read
In one paragraph

Article in Journal of theoretical biology, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. A Novel Stochastic Multi-Scale Model ofFrontiers in microbiology · 2018
    Article
  7. Review
  8. Computational fluid dynamics modeling ofJournal of aerosol science · 2016
    Article
  9. Modeling early events in Francisella tularensis pathogenesis.Frontiers in cellular and infection microbiology · 2014
    Article
  10. Article
  11. Article
  12. Deterministic models of inhalational anthrax in New Zealand white rabbits.Biosecurity and bioterrorism : biodefense strategy, practice, and science
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Judy DayMathematical Biosciences Institute, 3rd Floor Jennings Hall, The Ohio State University, Columbus, OH 43210, USA. judyday@utk.edu
Avner Friedman
Larry S Schlesinger

Funding

University of Iowa Clinical and Translational Science Program (TL1)UL1RR025755 · NCRR · OHIO STATE UNIVERSITY · PI JACKSON, REBECCA D · 2008 to 2011
$26.3M
TB and Innate Immune Regulation of Lung MacrophagesR01AI059639 · NIAID · OHIO STATE UNIVERSITY · PI SCHLESINGER, LARRY S. · 2005 to 2016
$3.2M
TB and Innate Immune Regulation of Lung MacrophagesR21AI059639 · NIAID · OHIO STATE UNIVERSITY · PI SCHLESINGER, LARRY S. · 2004 to 2004
$299k
NCRR NIH HHS UL1 RR025755NCRR NIH HHS UL1RR025755NIAID NIH HHS AI059639NIAID NIH HHS R01 AI059639NIAID NIH HHS R21 AI059639
6 · The paper itself

Abstract

Inhalation anthrax, an often fatal infection, is initiated by endospores of the bacterium Bacillus anthracis, which are introduced into the lung. To better understand the pathogenesis of an inhalation anthrax infection, we propose a two-compartment mathematical model that takes into account the documented early events of such an infection. Anthrax spores, once inhaled, are readily taken up by alveolar phagocytes, which then migrate rather quickly out of the lung and into the thoracic/mediastinal lymph nodes. En route, these spores germinate to become vegetative bacteria. In the lymph nodes, the bacteria kill the host cells and are released into the extracellular environment where they can be disseminated into the blood stream and grow to a very high level, often resulting in the death of the infected person. Using this framework as the basis of our model, we explore the probability of survival of an infected individual. This is dependent on several factors, such as the rate of migration and germination events and treatment with antibiotics.

Indexed as

Inhalation ExposureModels, BiologicalAnthraxAnti-Bacterial AgentsBacillus anthracisComputer SimulationHost-Pathogen InteractionsHumansIntracellular SpaceMicrobial ViabilityPhagocytosisSkin Diseases, BacterialAnti-Bacterial Agents

Identifiers

PMID21295589
PMCPMC3253853

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.